Hvivo
Hvivo, a leading clinical research organisation headquartered in Great Britain, specialises in the development and testing of innovative therapies and vaccines. Founded in 2006, the company has established itself as a pioneer in the field of human challenge studies, providing unique insights into infectious diseases. With operational hubs across Europe and North America, Hvivo offers a range of services, including clinical trial management and laboratory services, that are tailored to meet the needs of biopharmaceutical clients. Notable for its state-of-the-art facilities and expertise in respiratory and viral infections, Hvivo has achieved significant milestones, including partnerships with major pharmaceutical companies. Its commitment to advancing medical research positions Hvivo as a trusted partner in the industry, driving forward the development of life-saving treatments and vaccines.
DitchCarbon Score
How does Hvivo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hvivo's score of 43 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hvivo's reported carbon emissions
In 2024, hVIVO reported total carbon emissions of approximately 192,400 kg CO2e, a significant increase from about 148,100 kg CO2e in 2023 and about 104,300 kg CO2e in 2022. The emissions breakdown for 2024 includes Scope 1 emissions of about 14,900 kg CO2e, primarily from stationary combustion, and Scope 2 emissions of approximately 162,800 kg CO2e from purchased electricity. Additionally, Scope 3 emissions, which encompass business travel, accounted for about 14,700 kg CO2e. hVIVO has not set specific reduction targets or initiatives as part of their climate commitments, nor do they participate in initiatives such as the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organization, indicating that all reported figures are directly from hVIVO plc. Overall, hVIVO's emissions have shown an upward trend over the past three years, highlighting the need for enhanced climate strategies and commitments to mitigate their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 63,800 | 00,000 | 00,000 |
| Scope 2 | 12,900 | 00,000 | 000,000 |
| Scope 3 | 27,600 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hvivo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
